Antioxidant BHT 264
CAS:128-37-0
Purity:99%
Contact Now
We will contact you as soon as possible
Your Location:Home >Products >APi >151096-09-2

Product Details
Quality manufacturer supply Moxifloxacin 151096-09-2 in stock with high standard We supply high quality Moxifloxacin (CAS 151096-09-2), in stock, factory directly supply to clients, lower prices, more competitiveness.
Moxifloxacin is Almost white crystalling power, while it's Molecular Formula is C21H24FN3O4. Moxifloxacin is an antibiotic for the treatment of bacterial infections like bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
The CAS number of Moxifloxacin is 151096-09-2.
More information of Moxifloxacin 151096-09-2 are:
|
Synonyms |
3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-,(4aS-cis)-;Izilox;Moxifloxacine;Vigamox;Moxifloxacin; |
|
CAS Number |
151096-09-2 |
|
Molecular Formula |
C21H24FN3O4 |
|
Molecular Weight |
401.438 |
|
Density |
1.409 g/cm3 |
|
Melting Point |
203-208 ºC |
|
Boiling Point |
636.4 ºC at 760 mmHg |
|
Flash Point |
338.7 ºC |
|
PSA |
83.80000 |
|
LogP |
2.76430 |
|
Pka |
6.43±0.50(Predicted) |
Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039), used to treat a number of infections, including: respiratory tract infections, cellulitis, anthrax, intraabdominal infections, endocarditis, meningitis, and tuberculosis. It is marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. In the United States, moxifloxacin is licensed for the treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community acquired pneumonia, complicated and uncomplicated skin and skin structure infections, and complicated intra-abdominal infections.[5] In the European Union, it is licensed for acute bacterial exacerbations of chronic bronchitis, non-severe community-acquired pneumonia, and acute bacterial sinusitis.
InChI:InChI=1/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
Articles related to Moxifloxacin:
|
Article |
Source |
|
Preparation method of moxifloxacin |
- Paragraph 0029-0038, (2021/05/08) |
|
Fluorescence quenching study of moxifloxacin interaction with calf thymus DNA |
Lv, Yun-Kai,Li, Pan,Jiao, Miao-Lun,Liu, Bao-Sheng,Yang, Chao , p. 202 - 209 (2014/04/03) |
Huaihua Yuanyanda Biotechnology Co., Ltd is a quality supplier and manufacturer of Moxifloxacin . You can buy high quality, low price Moxifloxacin 151096-09-2 here. Contact us.